自作为皮肤癌的向治疗方法:评估自然和合成分子干预措施
Md Liakot Ali1,2, Amdad Hossain Roky2,3, S M Asadul Karim Azad2,3
1Department of Pharmacy, University of Chittagong, Chattogram 4331, Bangladesh.
Cancer pathogenesis and therapy
|October 7, 2024
概括
准细胞自,一个细胞过程,显示出皮肤癌治疗的前景. 调节器是有效和安全的,为这种流行恶性瘤提供新的治疗途径.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生化学
背景情况:
- 皮肤癌是一种广泛的恶性瘤,发病率越来越高.
- 自,细胞降解过程,在皮肤癌的发展和进展中起着双重作用.
- 调节自为皮肤癌治疗具有显著的治疗潜力.
研究的目的:
- 系统地审查皮肤癌和自之间的关系.
- 调查自调节剂在皮肤癌中的贡献和机制.
- 评估自调节作为治疗策略的有效性和安全性.
主要方法:
- 系统的文献审查.
- 对皮肤癌中自调节剂的现有研究进行分析.
- 阐明已识别的化合物的生理作用机制.
主要成果:
- 多种多样的自调节器在皮肤癌治疗中表现有前途.
- 每种化合物都通过不同的,明确的生理机制起作用.
- 在人体或动物模型中,没有报告天然,合成或半合成化合物的显著不良影响.
结论:
- 针对自是一种有前途的治疗策略,用于皮肤癌.
- 自调节器提供了新的机制和治疗视角.
- 这些调节器的安全性概况表明一种可行的临床方法.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Skin Cancer
4.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K


